CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Pfizer, Inc. vs. Genentech, Inc.

Explore the PTAB proceeding IPR2017-02063 filed by Pfizer, Inc. on 2017-09-06. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2017-02063

Filing Date

2017-09-06

Accorded Filing Date

2017-09-06

Institution Decision Date

2018-02-21

Last Modified Date

—

Proceeding Type

IPR

Termination Date

2018-10-03

Trial Status

Final Written Decision

Parties & Counsel

Petitioner

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 09208649
Respondent Patent Number 7846441
Legal Expiration Date
2018-12-10 Expired (Term Ended)
Injunction Viability (35 U.S.C. § 283) Statutorily Barred
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

1 Total

Proceeding Status

Final Written Decision

Administrative Patent Judges (APJ Panel)

Panel assignment tracked upon institution decision entry

Board Decisions & Rulings (1)

Final Decision 2018-10-03
FINAL WRITTEN DECISION 35 U.S.C. § 318(a) and 37 C.F.R. § 42.73 AND RELATED ORDERS
35 USC 318, 37 CFR 42.221, 37 CFR 42.5, 37 CFR 42.73

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 3 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 2 proceedings
🏛️
USPTO PTAB Trials 7 proceedings
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (3): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (9 found):
PTAB: 7 U.S. Courts: 2
USPTO PTAB Trial 2017-10-03
IPR2018-00016

Pfizer, Inc. v. Genentech, Inc.

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2017-08-25
IPR2017-01960

Samsung Bioepis Co., Ltd. v. Genentech, Inc.

U.S. Continuation Sibling (7892549)
Status: Final Written Decision
USPTO PTAB Trial 2017-03-21
IPR2017-01121

Celltrion, Inc. et al. v. Genentech, Inc.

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2017-03-21
IPR2017-01122

Celltrion, Inc. et al. v. Genentech, Inc.

U.S. Continuation Sibling (7892549)
Status: Final Written Decision
USPTO PTAB Trial 2017-01-20
IPR2017-00739

Hospira, Inc. et al. v. Genentech, Inc.

U.S. Continuation Sibling (7892549)
Status: Institution Denied
USPTO PTAB Trial 2017-01-20
IPR2017-00731

Hospira, Inc. et al. v. Genentech, Inc.

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2017-01-20
IPR2017-00737

Hospira, Inc. et al. v. Genentech, Inc.

U.S. Continuation Sibling (7892549)
Status: Final Written Decision
U.S. District Court 2018-09-04
1:18-cv-01363

Genentech, Inc. v. Samsung Bioepis Co., Ltd.

Asserted Patent
Status: DED
U.S. District Court 2018-01-12
1:18-cv-00095

Genentech, Inc. v. Celltrion, Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

69
26

FINAL WRITTEN DECISION 35 U.S.C. § 318(a) and 37 C.F.R. § 42.73 AND RELATED ORDERS Paper

2018-10-03 FILING PARTY: BOARD
25

Decision Institution of Inter Partes Review and Grant of Motion for Joinder Paper

2018-02-21 FILING PARTY: BOARD
24

Second Updated Mandatory Notices Paper

2018-02-02 FILING PARTY: PATENT OWN
23

Petitioners Updated Mandatory Notices Paper

2018-02-01 FILING PARTY: PETITIONER
22

Decision - Petitioner's Motions for Pro Hac Vice Admission of Sarah K. Tsou, Benjamin A. Lasky, Christopher J. Citro, and Mark C. McLennan Paper

2018-02-01 FILING PARTY: BOARD

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc